Advertisement
UK markets close in 4 hours 25 minutes
  • FTSE 100

    8,091.95
    +51.57 (+0.64%)
     
  • FTSE 250

    19,690.09
    -29.28 (-0.15%)
     
  • AIM

    754.85
    +0.16 (+0.02%)
     
  • GBP/EUR

    1.1661
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2506
    +0.0044 (+0.35%)
     
  • Bitcoin GBP

    50,770.06
    -2,363.20 (-4.45%)
     
  • CMC Crypto 200

    1,352.93
    -29.64 (-2.14%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.93
    +0.12 (+0.14%)
     
  • GOLD FUTURES

    2,340.10
    +1.70 (+0.07%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,972.72
    -115.98 (-0.64%)
     
  • CAC 40

    8,028.15
    -63.71 (-0.79%)
     

Insights into the Cash Flows and Valuations of Editas Medicine

Insights into the Cash Flows and Valuations of Editas Medicine

Since the beginning of 2018, Editas Medicine’s (EDIT) share price has risen 5.1% to close at $36.06 on May 23. The stock touched a high of $46 on March 9 and a low of $43.1 on April 30.